ESR1 and breast cancer: Collectively, the observations that NNAT is transcriptionally regulated by E2F4 and that overexpression of NNAT decreased ER + breast cancer cell proliferation suggest that cell cycle inhibition in response to ROS or PPAR signaling is potentially sensed and reinforced by NNAT.